Welcome to the official website of COST Action TD1206 "StanDerm"

About the Action


Action Chair

Prof. Swen Malte John
Institute for interdisciplinary Dermatological Prevention
and Rehabiliation,
University of Osnabrück, Department of Dermatology,
Environmental Medicine and Health Theory
Am Finkenhügel 7a
49076 Osnabrück, Germany
Fax: (0049) (0) 541 969 2445
Phone: (0049) (0) 541 969 2357
sjohn(at) | 

Action Vice Chair

Dr. Sanja Kezic
Academic Medical Center
Meibergdreef 15
1100 AZ Amsterdam, Netherlands
Phone: (0031) (020) 566 5321

Action Science Officer

Estelle Emeriau
COST Office
Avenue Louise 149
1050 Brussels, Belgium
Fax: 0032 (0) 2 533 38 90
Phone: 0032 (0) 2 533 38 68

Find the relevant COST Office website describing the Action.

Our funding is through COST (European Cooperation in Science and Technology)


Strong concerns on self-testing for contact sensitization to hair dyes

22 March 2017 | Statement by StanDerm

StanDerm expresses its concern vis-à-vis the position of the European Commission with regard to skin testing methods recommended by the manufacturers of oxidative hair dyes. Different views have been expressed and StanDerm fully supports the position taken by the hairdressing social partners (Coiffure EU and UNI Europa), namely to abandon the self-testing method and to replace it with a scientifically based questionnaire, and very importantly, to consult a dermatologist/allergologist. StanDerm adopted the following statement. In order to find out whether consumers are allergic to certain dyes and colouring substances, manufacturers recommend that a self-test is carried out before product use. In addition to the methodological and scientific concerns of the social partners on the self-test method, it appears that a significant proportion of the hairdressers applying this method are unable to interpret its results nor do they have the appropriate training made available. The social partners call for the abolition of the self-testing method.

Occupational dermatoses in Spain

09 March 2017 | Annual training course organized by Hospital del Mar in Barcelona.

For the 7th consecutive time, the Hospital del Mar in Barcelona organized under the guidance of Prof. Dr. Ana Gimenez Arnau the annual training course on occupational dermatoses with an interdisciplinary approach devoted to the various facets of this disease. Particular attention was given to the patient treatment, which involves coordinated care provided by different disciplines. Also in Spain occupational dermatoses affects about 10% of the working population, having a significant socio- economic impact, amongst others due to the reported sick leave and loss of job and/or retraining. Prevention is therefore an important requisite as emphasized during the course. Ana Gimenez Arnau also drew attention to the position paper of StanDerm on the need to standardize patient management and prevention of occupational skin diseases throughout Europe.  The paper will be published in May at the occasion of the final workshop of StanDerm (Berlin, 18-19 May).  
© StanDerm

We are up there with the best!

20 January 2017 | StanDerm contributions on OSC amongst top 20 2016 JEADV articles

Amongst the most shared and cited 2016 JEADV articles appear StanDerm´s contributions published in the JEADV supplement volume 30, S 3. The publication “Non-melanoma Skin Cancer by Solar UV. The Neglected Occupational Threat”, provides an overview and highlights new research on the current European status quo regarding epidemiology, risk assessment and UVR exposure measurement, legal management and health care services provided to affected workers. The consensus report, most shared, calls European member states to recognize NMSC as an occupational disease and the EU Commission to revise the 2006 Directive on Artificial Optical Radiation (2006/25EC) to include solar UV radiation within its scope.

Argentinean Congress of Dermatology

08 December 2016 | International exchange on the prevention of occupational skin diseases in Buenos Aires

At the 65th course on continuous medical education in Dermatology in Buenos Aires (22-26 November 2016), StanDerm was represented by Dr. José Alfonso (National Institute of Occupational Health/STAMI, Norway) with a series of lectures on occupational skin diseases. He focused on European standards for the prevention of occupational skin diseases as well as on the UV exposure risks for outdoor workers. Dr. An Goossens (Belgium), also member of StanDerm, reflected on important aspects of contact dermatitis mainly caused by contact with chemical or physical agents. This meeting was an excellent opportunity to exchange amongst experts from Europe, Argentina and South America on the various prevention approaches applied to improve workers´ risks of developing a work-related skin disease and to bring forward joint research activities. Of particular interest were presentations made by the Research Group on Contact Dermatitis from the Argentinean Society of Dermatology on results gained from work-related contact dermatitis projects initiated after the inclusion of Argentina in StanDerm.    An Goossens, José Hernan Alfonso (from left to right)
© StanDerm

Sucessful StanDerm WG Summit and Workshop

20 October 2016 | Krakow, 12-13 October 2016

meeting of working groups an workshop was held in Krakow, Poland on 12 and 13 October 2016  hosted by Prof. Dr. Radoslaw Spiewak from the Jagiellonian University Krakow, Department of Experimental Dermatology and Cosmetology. 
A total of 64 StanDerm members from 23 countries met in a combination of parallel and plenary sessions. A working group summit, carried out on Day 1, focused on important research issues of the working groups. At the end of Day 1 a core group meeting was held to discuss StanDerm's final workshop 2017 in Berlin. At the workshop on Day 2 keynote speakers addressed selected topics important to the field of improved prevention and patient management in OSD. 





In Europe:

  • occupational skin diseases (OSD) represent up to 30% of occupational diseases
  • OSD related costs exceed 5 billion €/year by loss of productivity
  • there are isolated efforts of OSD prevention in some countries
  • there is no coordinated action between the stakeholders at national and international levels
  • surveillance and diagnostics of OSD are hampered by lack of common monitoring of new allergens  in workplaces. 

The EU Commission therefore defined lacking prevention of OSD a top priority problem.  

"StanDerm" comprises 31 countries and aims at coordinating activities relevant for OSD prevention, including basic sciences (aetiology and individual susceptibility), epidemiological surveillance, transnational and applied clinical research.This involves regulatory issues (e.g. REACH), development of interdisciplinary workers' education concepts, identifying individual susceptibility markers enabling tailored prevention and pre-employment counselling.  

This COST Action will allow setting up transnational controlled intervention studies in large cohorts in high-risk professions. The outcome will be evidence-based common European standards on OSD prevention and patient management. This will provide a safer working environment and targeted early intervention for workers throughout Europe, enhancing economic competitiveness, particularly of small and medium-sized enterprises (SMEs).

Memorandum of Unterstanding (MoU) is signed by the participating governments of the COST countries. The MoU details the content, the arrangement and related activities for the implementation of the Action.